Chevy Chase Trust Holdings LLC Sells 413 Shares of The Clorox Company (NYSE:CLX)

Chevy Chase Trust Holdings LLC trimmed its stake in The Clorox Company (NYSE:CLX) by 0.5% during the first quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 87,422 shares of the company’s stock after selling 413 shares during the period. Chevy Chase Trust Holdings LLC’s holdings in Clorox were worth $12,873,000 at the end of the most recent reporting period.

Other institutional investors have also made changes to their positions in the company. Norges Bank acquired a new stake in shares of Clorox in the fourth quarter worth $259,041,000. FMR LLC grew its stake in Clorox by 75.4% in the 4th quarter. FMR LLC now owns 1,361,758 shares of the company’s stock valued at $221,163,000 after buying an additional 585,526 shares during the last quarter. Marshall Wace LLP raised its holdings in Clorox by 549.8% in the 4th quarter. Marshall Wace LLP now owns 542,726 shares of the company’s stock worth $88,144,000 after acquiring an additional 459,203 shares during the period. ExodusPoint Capital Management LP lifted its position in Clorox by 187.9% during the 4th quarter. ExodusPoint Capital Management LP now owns 698,900 shares of the company’s stock worth $113,508,000 after acquiring an additional 456,114 shares during the last quarter. Finally, Man Group plc boosted its holdings in Clorox by 154.6% during the fourth quarter. Man Group plc now owns 570,503 shares of the company’s stock valued at $92,655,000 after acquiring an additional 346,449 shares during the period. 78.53% of the stock is owned by institutional investors.

Wall Street Analyst Weigh In

A number of equities analysts have recently commented on the company. Morgan Stanley dropped their price objective on Clorox from $165.00 to $150.00 and set an “equal weight” rating on the stock in a research note on Tuesday, May 6th. JPMorgan Chase & Co. dropped their price target on Clorox from $151.00 to $144.00 and set a “neutral” rating on the stock in a research report on Tuesday, May 6th. UBS Group cut their price target on Clorox from $176.00 to $154.00 and set a “neutral” rating for the company in a report on Thursday, April 17th. Citigroup lowered their price objective on shares of Clorox from $165.00 to $150.00 and set a “neutral” rating on the stock in a research note on Monday, April 14th. Finally, Barclays cut their target price on shares of Clorox from $134.00 to $129.00 and set an “underweight” rating for the company in a research note on Wednesday, May 7th. Three research analysts have rated the stock with a sell rating, ten have issued a hold rating and one has assigned a buy rating to the company’s stock. According to MarketBeat, Clorox presently has an average rating of “Hold” and a consensus price target of $153.00.

Insiders Place Their Bets

In related news, Director Pierre R. Breber purchased 4,000 shares of the firm’s stock in a transaction that occurred on Wednesday, May 7th. The shares were acquired at an average price of $136.57 per share, with a total value of $546,280.00. Following the purchase, the director now directly owns 4,000 shares in the company, valued at $546,280. This represents a ? increase in their ownership of the stock. The purchase was disclosed in a legal filing with the SEC, which is available through the SEC website. Corporate insiders own 0.57% of the company’s stock.

Clorox Stock Down 2.1%

Shares of CLX stock opened at $119.46 on Thursday. The Clorox Company has a one year low of $119.41 and a one year high of $171.37. The company has a debt-to-equity ratio of 13.07, a current ratio of 0.74 and a quick ratio of 0.44. The stock has a fifty day moving average price of $132.05 and a 200 day moving average price of $145.95. The stock has a market cap of $14.72 billion, a P/E ratio of 21.45, a price-to-earnings-growth ratio of 2.76 and a beta of 0.54.

Clorox (NYSE:CLX) last released its quarterly earnings data on Monday, May 5th. The company reported $1.45 EPS for the quarter, missing analysts’ consensus estimates of $1.57 by ($0.12). The business had revenue of $1.67 billion for the quarter, compared to the consensus estimate of $1.74 billion. Clorox had a return on equity of 324.23% and a net margin of 9.89%. Clorox’s revenue was down 8.0% on a year-over-year basis. During the same period in the previous year, the business posted $1.71 earnings per share. Analysts predict that The Clorox Company will post 7.15 earnings per share for the current year.

Clorox Company Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.